Covid-19 tsunami that hit India must also be added to the findings of a new corona variant. At least a triple mutant variant of Covid-19 was detected in India.
The triple mutation means a combination of three different strains of Covid-19 and forming a new variant. According to one report, this triple mutant is an interest variant not an attention variant.
India Cases Increases Due to Double Mutants
Previously, the surge in India was estimated by a number of health experts because of the double mutant. With the finding of this triple mutant, it further adds to the problem in the Bollywood country.
The NDTV News report said cases in states like West Bengal, Maharashtra and Delhi are believed to have been pushed because of the mutants.
“This is a transmissible variant. It makes a lot of people sick very quickly. We are constantly working on vaccines. For that we need knowledge of disease. But we need to sort by war-ready conditions,” said McGill University Professor of Epidemiology, Madhukar Pai. , quoted from The Independent, Tuesday (27/4/2021).
There is no longer any reason to delay detecting these mutants. Because according to him, the delay in detecting multiple mutants will contribute to the current surge in the virus in India.
New Variants Have an Impact on Vaccines in Circulation
The emerge of new variants will certainly have an impact on the vaccines in circulation. In a thread on Twitter, researcher Vinod Scaria said additional experimental data was needed to assess the efficacy of the vaccine.
In recent times, India has had to feel the Covid-19 tsunami. There was a significant increase in positive cases and deaths.
The Independent report states that since the pandemic began, India has recorded 15.6 million Covid-19 cases with 182,500 deaths. Approximately 1.1 million were recorded in just 4 days.
Within 24 hours of last week, there were 295,000 cases and 2,000 deaths in India. With this record, India has become the global epicenter of the Covid-19 outbreak.
Read now: Covid-19 Vaccine in Pill Form Starts Clinical Trials in June
